Issue 5: HVP Has Launched a Global COVID Lab Meeting to Accelerate Vaccine and Therapeutic R&D Efforts

Apr 29, 2020

By Wayne Koff, Ph.D.

President & CEO


On May 7th, the Human Vaccines Project is launching the Global COVID Lab Meeting. This bi-weekly webinar is open to scientists and policy makers globally. Leading scientists will present the latest research pertaining to COVID-19 therapeutic and vaccine development. Our goal is to identify the most critical research efforts and the most promising projects to facilitate global information exchange and data transparency.

First Session: May 7th at 10 AM EST
Dr. James E. Crowe Jr., Director of the Vanderbilt Vaccine Center, will present an overview of his efforts to advance human monoclonal antibody therapeutics for SARS-CoV-2. Dr. Crowe’s lab is one of the leading groups globally working on antibody identification, and is targeting starting clinical studies early this summer for SARS-CoV-2 therapeutics.


Register for the HVP COVID Report: